These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2399902

  • 1. Transformation of polycythemia vera to Ph-positive chronic myelogenous leukemia.
    Haq AU.
    Am J Hematol; 1990 Oct; 35(2):110-3. PubMed ID: 2399902
    [Abstract] [Full Text] [Related]

  • 2. Transition of polycythemia vera to chronic myeloid leukaemia.
    Saviola A, Fiorani C, Ferrara L, Mazzocchi V, Zucchini P, Temperani P, Longo G, Emilia G, Torelli G.
    Eur J Haematol; 2005 Sep; 75(3):264-6. PubMed ID: 16104886
    [Abstract] [Full Text] [Related]

  • 3. Acute myeloblastic leukemia with polycythemia vera. Treated with busulfan and phlebotomy.
    Dittmar K.
    N Y State J Med; 1979 Apr; 79(5):758-61. PubMed ID: 286175
    [No Abstract] [Full Text] [Related]

  • 4. Malignant histiocytosis occurring with acute myelogenous leukemia in a patient with longstanding polycythemia vera.
    Baer MR, Gleaton JH, Salhany KE, Glick AD.
    Cancer; 1987 Feb 01; 59(3):489-95. PubMed ID: 3466664
    [Abstract] [Full Text] [Related]

  • 5. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
    Abdulkarim K, Ridell B, Johansson P, Kutti J, Safai-Kutti S, Andréasson B.
    Eur J Haematol; 2011 Feb 01; 86(2):148-55. PubMed ID: 21059102
    [Abstract] [Full Text] [Related]

  • 6. [Clinical course and transformation of polycythemia vera and its relation to applied therapy].
    Burger T, Schmelczer M, Molnár L, Pajor L, Koszorús S.
    Orv Hetil; 1987 Dec 27; 128(52):2723-30. PubMed ID: 3431872
    [No Abstract] [Full Text] [Related]

  • 7. Coexistent chronic lymphocytic leukemia and polycythemia vera requiring no treatment.
    Botelho de Sousa A, Gouveia J.
    Med Oncol Tumor Pharmacother; 1989 Dec 27; 6(3):239-40. PubMed ID: 2615527
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR.
    Semin Hematol; 1986 Apr 27; 23(2):132-43. PubMed ID: 3704665
    [Abstract] [Full Text] [Related]

  • 9. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
    Ellis JT, Peterson P, Geller SA, Rappaport H.
    Semin Hematol; 1986 Apr 27; 23(2):144-55. PubMed ID: 3704666
    [Abstract] [Full Text] [Related]

  • 10. Natural history and management of polycythemia vera.
    Hoffman R, Wasserman LR.
    Adv Intern Med; 1979 Apr 27; 24():255-85. PubMed ID: 371361
    [No Abstract] [Full Text] [Related]

  • 11. The treatment of polycythemia vera.
    Wasserman LR.
    Semin Hematol; 1976 Jan 27; 13(1):57-78. PubMed ID: 1251223
    [No Abstract] [Full Text] [Related]

  • 12. Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia.
    Johansson P, Safai-Kutti S, Lindstedt G, Suurküla M, Kutti J.
    Acta Haematol; 2002 Jan 27; 108(1):1-7. PubMed ID: 12145459
    [Abstract] [Full Text] [Related]

  • 13. Essential thrombocythemia following polycythemia vera: an unusual sequence.
    Randi ML, Barbone E, Zerbinati P, Soini B, Rossi C, Girolami A.
    J Med; 1996 Jan 27; 27(5-6):363-8. PubMed ID: 9151204
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow findings in blast phase of polycythemia vera.
    Hidalgo López JE, Carballo-Zarate A, Verstovsek S, Wang SA, Hu S, Li S, Xu J, Zuo W, Tang Z, Yin CC, Medeiros LJ, Bueso-Ramos CE, Tang G.
    Ann Hematol; 2018 Mar 27; 97(3):425-434. PubMed ID: 29285580
    [Abstract] [Full Text] [Related]

  • 15. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S, Stock W, Godwin J, Fisher SG.
    Am J Hematol; 1996 May 27; 52(1):42-6. PubMed ID: 8638610
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A.
    Semin Hematol; 1999 Jan 27; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [Abstract] [Full Text] [Related]

  • 18. Acute leukemia as a transformation after polycythemia vera.
    Eisemann G, Kahn M.
    South Med J; 1982 Jun 27; 75(6):772-3. PubMed ID: 6953605
    [Abstract] [Full Text] [Related]

  • 19. Polycythemia vera: scientific advances and current practice.
    Tefferi A, Spivak JL.
    Semin Hematol; 2005 Oct 27; 42(4):206-20. PubMed ID: 16210034
    [Abstract] [Full Text] [Related]

  • 20. Polycythemia rubra vera progressing to Ph1-positive chronic myelogenous leukemia.
    Hoppin EC, Lewis JP.
    Ann Intern Med; 1975 Dec 27; 83(6):820-3. PubMed ID: 1060394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.